| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |